Incidence of adverse events
| Event, n (%) . | Non-del(5q) (n = 32) . | Del(5q) (n = 7) . | ||
|---|---|---|---|---|
| Grade 3 . | Grade 4 . | Grade 3 . | Grade 4 . | |
| Thrombocytopenia | 9 (28.1) | 10 (31.3) | 3 (42.9) | 2 (28.6) |
| Neutropenia | 8 (25.0) | 15 (46.9) | 2 (28.6) | 5 (71.4) |
| Anemia | 2 (6.3) | 0 (0.0) | 4 (57.1) | 0 (0.0) |
| Diarrhea | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Constipation | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Nausea | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Vomiting | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Pruritus and rash | 5 (15.6) | 0 (0.0) | 1 (14.3) | 0 (0.0) |
| Muscle cramps | 2 (6.3) | 0 (0.0) | 2 (28.6) | 0 (0.0) |
| Fatigue | 2 (6.3) | 0 (0.0) | 1 (14.3) | 0 (0.0) |
| Infections | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Deep venous thrombosis | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Event, n (%) . | Non-del(5q) (n = 32) . | Del(5q) (n = 7) . | ||
|---|---|---|---|---|
| Grade 3 . | Grade 4 . | Grade 3 . | Grade 4 . | |
| Thrombocytopenia | 9 (28.1) | 10 (31.3) | 3 (42.9) | 2 (28.6) |
| Neutropenia | 8 (25.0) | 15 (46.9) | 2 (28.6) | 5 (71.4) |
| Anemia | 2 (6.3) | 0 (0.0) | 4 (57.1) | 0 (0.0) |
| Diarrhea | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Constipation | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Nausea | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Vomiting | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Pruritus and rash | 5 (15.6) | 0 (0.0) | 1 (14.3) | 0 (0.0) |
| Muscle cramps | 2 (6.3) | 0 (0.0) | 2 (28.6) | 0 (0.0) |
| Fatigue | 2 (6.3) | 0 (0.0) | 1 (14.3) | 0 (0.0) |
| Infections | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Deep venous thrombosis | 1 (3.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |